智通财经APP讯,玮俊生物科技(00660)发布公告,于2025年3月20日因金额为175万港元的可换股债券以每股0.25港元转换及发行股份700万股。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.